Tragore: You are, of course, sadly correct that the drugs already on market "don't actually do much". In fact they sadly do precious LITTLE of real value. To have a slightly less 'value-lacking' medicine about should of course not be the end-aim in the fight against AD - JIMHO, of course. But even another (almost doing nothing) medicine might become a REALLY BIG commercial success...That will be a good scenario for ACW share-holders but not necessarily a great scenario for AD sufferers. JIMHO.
Time will tell.
wasa
Ann: Managing Director's AGM Presentation, page-49
-
- There are more pages in this discussion • 2 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add ACW (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
2.4¢ |
Change
0.000(0.00%) |
Mkt cap ! $73.62M | |||
| Open | High | Low | Value | Volume |
| 2.4¢ | 2.5¢ | 2.4¢ | $163.1K | 6.756M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 27 | 8628555 | 2.3¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 2.4¢ | 585898 | 4 |
View Market Depth
| Last trade - 12.10pm 30/09/2024 (20 minute delay) ? |
| ACW (ASX) Chart |